Alpha9 Theranostics

Alpha9 Theranostics is a leading clinical-stage radiopharmaceutical company based in Vancouver, BC, focused on advancing a distinctive portfolio of molecules designed to treat cancer cells with unparalleled precision. By harnessing the power of radiopharmaceuticals, Alpha9 is not only enhancing cancer care but also illuminating new possibilities in precision medicine.

The company employs a bespoke iterative process to optimize each component of its molecules, including binders, linkers, chelators, and radioisotopes, supported by state-of-the-art infrastructure and in-house formulation expertise. With a leadership team boasting decades of experience in oncology drug development, Alpha9 is backed by top-tier investors and founders with extensive knowledge in the field of radiopharmaceuticals.

Generated from the website